A Rapid, Low-risk Approach for Process Transfer of Biologics from Development to Manufacturing Scale

Thank you - Your Download is Available Below

A Rapid, Low-risk Approach for Process Transfer of Biologics from Development to Manufacturing Scale

PDF | 1.4 MB

A Rapid, Low-risk Approach for Process Transfer of Biologics from Development to Manufacturing Scale

This poster highlights a scaling methodology from the Ambr^®️ 15 Cell Culture to the Biostat STR^®️ 2000L without affecting the process or product quality. Using this scale-up approach, bioprocess scientists can develop faster, more cost-effective cell culture processes for their biologics manufacturing.

Clear form data

Please Complete the Form

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Thank you - Your Download is Available Below

A Rapid, Low-risk Approach for Process Transfer of Biologics from Development to Manufacturing Scale

A Rapid, Low-risk Approach for Process Transfer of Biologics from Development to Manufacturing Scale

Please Complete the Form

Complete Form to Access the File